[5] This unique ingredient stands out from generic saffron extracts thanks to its precise standardization and clinically-validated effects on satiety
At 4mg, the phase 2 trial showed 17.1% average weight loss at 48 weeks, which exceeds the maximum dose of semaglutide (14.9%) in its own trial
Many plans will cover these drugs if the patient is obese
Retatrutide could become the first obesity therapy to carry a secondary indication for liver fat management, which would dramatically expand its clinical relevance beyond weight loss alone
Thats where we celebrate your small victories like being consistent and working out five days this week, getting your steps in, lifting heavier, or meeting your water goals
Meanwhile, another study in The New England Journal of Medicine shows just 33% of the dose of one popular GLP-1 drove 72% of the weight loss at week 72 with a lower side effect profile